{"id":3390,"date":"2024-04-16T08:28:19","date_gmt":"2024-04-16T08:28:19","guid":{"rendered":"https:\/\/pharm.sinocurechem.com\/?p=3301"},"modified":"2024-04-16T08:28:19","modified_gmt":"2024-04-16T08:28:19","slug":"how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment","status":"publish","type":"post","link":"https:\/\/longchangextracts.com\/tr\/protionamidlerin-cigir-acan-mekanizmasi-tuberkuloz-tedavisinde-nasil-devrim-yaratiyor\/","title":{"rendered":"Protionamide'in \u00c7\u0131\u011f\u0131r A\u00e7an Mekanizmas\u0131 T\u00fcberk\u00fcloz Tedavisinde Nas\u0131l Devrim Yarat\u0131yor!"},"content":{"rendered":"

1.\u00a0<\/span>Genel Bak\u0131\u015f<\/span><\/b><\/b><\/p>\n

Prothionamide olarak da bilinen Protionamide, tiyoamid bile\u015fik s\u0131n\u0131f\u0131na ait sentetik bir antibakteriyel ajand\u0131r.<\/span><\/p>\n

\u00d6ncelikle t\u00fcberk\u00fcloz tedavisinde, \u00f6zellikle de hastan\u0131n di\u011fer birinci basamak anti-t\u00fcberk\u00fcloz ila\u00e7lara kar\u015f\u0131 diren\u00e7 geli\u015ftirdi\u011fi durumlarda kullan\u0131l\u0131r.<\/span><\/p>\n

Protionamid, \u00e7ok ilaca diren\u00e7li t\u00fcberk\u00fcloz (MDR-TB) ve yayg\u0131n ilaca diren\u00e7li t\u00fcberk\u00fcloz (XDR-TB) i\u00e7in ikinci basamak veya alternatif bir tedavi se\u00e7ene\u011fi olarak kullan\u0131lmaktad\u0131r.<\/span><\/p>\n

2.\u00a0<\/span>Kimyasal Yap\u0131 ve \u00d6zellikler<\/span><\/b><\/b><\/p>\n

A.\u00a0<\/span>Kimyasal Yap\u0131<\/span><\/b><\/b><\/p>\n

Protionamid, C7H7N3S molek\u00fcler form\u00fcl\u00fcne sahiptir.<\/span><\/p>\n

Kimyasal yap\u0131, bir amino grubu ve bir karbonil grubu eklenmi\u015f bir tiyazol halkas\u0131ndan (k\u00fck\u00fcrt ve azot i\u00e7eren be\u015f \u00fcyeli bir heterosiklik halka) olu\u015fur.<\/span><\/p>\n

Tiyazol halkas\u0131, karbonil grubu ve amino grubu, bile\u015fi\u011fin biyolojik aktivitesine ve fizikokimyasal \u00f6zelliklerine katk\u0131da bulunan temel yap\u0131sal \u00f6zelliklerdir.<\/span><\/p>\n

B.\u00a0<\/span>Fiziksel ve Kimyasal \u00d6zellikler<\/span><\/b><\/b><\/p>\n

G\u00f6r\u00fcn\u00fc\u015f: Beyaz ila kirli beyaz kristal toz<\/span><\/p>\n

Molek\u00fcler A\u011f\u0131rl\u0131k: 181,24 g\/mol<\/span><\/p>\n

Erime Noktas\u0131: 159-162\u00b0C<\/span><\/p>\n

Kaynama Noktas\u0131: \u0130yi tan\u0131mlanmam\u0131\u015f (kaynamadan \u00f6nce ayr\u0131\u015f\u0131r)<\/span><\/p>\n

\u00c7\u00f6z\u00fcn\u00fcrl\u00fck: Suda, etanolde ve di\u011fer polar organik \u00e7\u00f6z\u00fcc\u00fclerde \u00e7\u00f6z\u00fcn\u00fcr<\/span><\/p>\n

Eter ve benzen gibi polar olmayan \u00e7\u00f6z\u00fcc\u00fclerde az \u00e7\u00f6z\u00fcn\u00fcr<\/span><\/p>\n

Stabilite: Normal depolama ko\u015fullar\u0131nda nispeten kararl\u0131d\u0131r, Bozulmaya yol a\u00e7abilecek \u0131\u015f\u0131k ve \u0131s\u0131ya duyarl\u0131d\u0131r. Sulu \u00e7\u00f6zeltiler, \u00f6zellikle asidik veya bazik ko\u015fullar alt\u0131nda hidrolize duyarl\u0131 olabilir.<\/span><\/p>\n

Fonksiyonel Gruplar:<\/span><\/p>\n

Tiyazol halkas\u0131<\/span><\/p>\n

Karbonil (C=O) grubu<\/span><\/p>\n

Birincil amino (NH2) grubu<\/span><\/p>\n

Kutupluluk ve Y\u00fck:<\/span><\/p>\n

Protionamid, karbonil ve amino gruplar\u0131n\u0131n varl\u0131\u011f\u0131 nedeniyle polar bir molek\u00fcld\u00fcr.<\/span><\/p>\n

Fizyolojik pH'da, bile\u015fik a\u011f\u0131rl\u0131kl\u0131 olarak n\u00f6tr, iyonize olmayan formda bulunur.<\/span><\/p>\n

Spektroskopik \u00d6zellikler:<\/span><\/p>\n

UV-Vis Absorpsiyonu: Protionamid, kantitatif analiz i\u00e7in kullan\u0131labilen 280-290 nm civar\u0131nda absorpsiyon maksimumlar\u0131 sergiler.<\/span><\/p>\n

IR Spektroskopisi: Karbonil, amino ve tiyazol halkas\u0131 i\u00e7in karakteristik absorpsiyon bantlar\u0131 g\u00f6zlemlenebilir.<\/span><\/p>\n

NMR Spektroskopisi: 1H NMR ve 13C NMR spektrumlar\u0131, bile\u015fi\u011fin yap\u0131s\u0131 ve safl\u0131\u011f\u0131 hakk\u0131nda ayr\u0131nt\u0131l\u0131 bilgi sa\u011flar.<\/span><\/p>\n

3.\u00a0<\/span>Etki Mekanizmas\u0131<\/span><\/b><\/b><\/p>\n

Protionamid, antibakteriyel etkilerini g\u00f6stermek i\u00e7in bakteriyel enzim EthA (Enoyl-[acyl-carrier-protein] reductase) taraf\u0131ndan aktivasyon gerektiren bir \u00f6n ila\u00e7t\u0131r.<\/span><\/p>\n

Protionamide'in aktive edilmi\u015f formu, bakteri h\u00fccre duvar\u0131n\u0131n temel bile\u015fenleri olan mikolik asitlerin sentezine m\u00fcdahale eder.<\/span><\/p>\n

H\u00fccre duvar\u0131 b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn bu \u015fekilde bozulmas\u0131, bakteriyel b\u00fcy\u00fcmenin engellenmesine ve nihai h\u00fccre \u00f6l\u00fcm\u00fcne yol a\u00e7ar.<\/span><\/p>\n

4.\u00a0<\/span>\u00d6n \u0130la\u00e7 Aktivasyonu<\/span><\/b><\/b><\/p>\n

Protionamid bir \u00f6n ila\u00e7t\u0131r, yani antibakteriyel etkilerini g\u00f6stermek i\u00e7in metabolik aktivasyon gerektirir.<\/span><\/p>\n

Aktivasyon s\u00fcreci, EthA (Enoyl-[a\u00e7il-ta\u015f\u0131y\u0131c\u0131-protein] red\u00fcktaz) ad\u0131 verilen bir mikobakteriyel enzim taraf\u0131ndan Protionamid'in enzimatik d\u00f6n\u00fc\u015f\u00fcm\u00fcn\u00fc i\u00e7erir.<\/span><\/p>\n

EthA, Protionamid'in oksidatif aktivasyonunu katalize eden flavin adenin din\u00fckleotid (FAD) ba\u011f\u0131ml\u0131 bir monooksijenaz enzimidir.<\/span><\/p>\n

A.\u00a0<\/span>Etki Mekanizmas\u0131<\/span><\/b><\/b><\/p>\n

1.\u00a0<\/span>EthA arac\u0131l\u0131 Aktivasyon:<\/span><\/p>\n

Mycobacterium tuberculosis ve di\u011fer mikobakterilerdeki EthA enzimi Protionamide'in aktivasyonundan sorumludur.<\/span><\/p>\n

EthA, Protionamide'deki tiyoamid grubunun oksidasyonunu katalize ederek onu reaktif bir ara \u00fcr\u00fcne d\u00f6n\u00fc\u015ft\u00fcr\u00fcr.<\/span><\/p>\n

Protionamid'in bu aktive edilmi\u015f formunun, mikobakteriyel h\u00fccreler \u00fczerinde etkilerini g\u00f6steren birincil antibakteriyel ajan oldu\u011funa inan\u0131lmaktad\u0131r.<\/span><\/p>\n

2.\u00a0<\/span>Mikolik Asit Sentezinin Engellenmesi:<\/span><\/p>\n

Protionamide'in aktive edilmi\u015f formu, mikobakteriyel h\u00fccre duvar\u0131n\u0131n temel bile\u015fenleri olan mikolik asitlerin sentezine m\u00fcdahale eder.<\/span><\/p>\n

Mikolik asitler, mikobakteriyel h\u00fccre duvar\u0131n\u0131n yap\u0131sal b\u00fct\u00fcnl\u00fc\u011f\u00fc ve ge\u00e7irgenli\u011fi i\u00e7in kritik \u00f6neme sahip uzun zincirli, dall\u0131 zincirli ya\u011f asitleridir.<\/span><\/p>\n

Protionamide, bu hayati h\u00fccre duvar\u0131 bile\u015fenlerinin sentezini bozarak mikobakteriyel h\u00fccre duvar\u0131n\u0131n b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc tehlikeye atar ve h\u00fccre \u00f6l\u00fcm\u00fcne veya b\u00fcy\u00fcmenin engellenmesine yol a\u00e7ar.<\/span><\/p>\n

3.\u00a0<\/span>H\u00fccresel Metabolizma De\u011fi\u015fikli\u011fi:<\/span><\/p>\n

Mikolik asit sentezi \u00fczerindeki do\u011frudan etkilerine ek olarak, Protionamide'in aktive edilmi\u015f formu mikobakterilerdeki di\u011fer h\u00fccresel s\u00fcre\u00e7lere de m\u00fcdahale edebilir.<\/span><\/p>\n

Protionamid'in lipid metabolizmas\u0131, enerji \u00fcretimi ve di\u011fer temel h\u00fccresel i\u015flevlerde yer alan \u00e7e\u015fitli enzimlerin ifadesini veya aktivitesini etkileyebilece\u011fi \u00f6ne s\u00fcr\u00fclm\u00fc\u015ft\u00fcr.<\/span><\/p>\n

H\u00fccresel metabolizma \u00fczerindeki bu dolayl\u0131 etkiler, Protionamide'in antimikobakteriyel aktivitesine daha fazla katk\u0131da bulunabilir.<\/span><\/p>\n

B.\u00a0<\/span>\u00d6zg\u00fcll\u00fck ve Diren\u00e7<\/span><\/b><\/b><\/p>\n

Protionamide'in etki mekanizmas\u0131 \u00f6ncelikle mikobakterileri, \u00f6zellikle de t\u00fcberk\u00fcloz etkeni olan Mycobacterium tuberculosis'i hedef almaktad\u0131r.<\/span><\/p>\n

EthA arac\u0131l\u0131 aktivasyon s\u00fcreci, etki mekanizmas\u0131nda \u00e7ok \u00f6nemli bir ad\u0131md\u0131r ve EthA enzimindeki mutasyonlar veya de\u011fi\u015fiklikler Protionamide kar\u015f\u0131 dirence yol a\u00e7abilir.<\/span><\/p>\n

EthA genindeki mutasyonlar gibi diren\u00e7 mekanizmalar\u0131n\u0131n anla\u015f\u0131lmas\u0131, ilaca diren\u00e7li t\u00fcberk\u00fcloz tedavisinde Protionamide kullan\u0131m\u0131n\u0131n optimize edilmesi i\u00e7in \u00f6nemlidir.<\/span><\/p>\n

Genel olarak, Protionamide'in ayr\u0131nt\u0131l\u0131 etki mekanizmas\u0131, \u00f6n ilac\u0131n EthA arac\u0131l\u0131 aktivasyonunu, ard\u0131ndan mikolik asit sentezinin ve potansiyel olarak di\u011fer h\u00fccresel s\u00fcre\u00e7lerin bozulmas\u0131n\u0131 ve sonu\u00e7ta mikobakteriyel b\u00fcy\u00fcmenin ve h\u00fccre \u00f6l\u00fcm\u00fcn\u00fcn engellenmesini i\u00e7erir.<\/span><\/p>\n

5.\u00a0<\/span>Terap\u00f6tik Uygulamalar:<\/span><\/b><\/b><\/p>\n

Protionamide'in birincil kullan\u0131m alan\u0131, \u00f6zellikle hastan\u0131n izoniazid ve rifampisin gibi di\u011fer birinci basamak anti-t\u00fcberk\u00fcloz ila\u00e7lara diren\u00e7 geli\u015ftirdi\u011fi durumlarda t\u00fcberk\u00fcloz tedavisidir.<\/span><\/p>\n

Tedavi rejiminin etkinli\u011fini art\u0131rmak i\u00e7in genellikle pirazinamid, etambutol ve florokinolonlar gibi di\u011fer anti-t\u00fcberk\u00fcloz ajanlarla birlikte kullan\u0131l\u0131r.<\/span><\/p>\n

Protionamid, hastan\u0131n standart c\u00fczzam tedavilerine diren\u00e7 geli\u015ftirdi\u011fi durumlarda, bir ba\u015fka mikobakteriyel enfeksiyon olan c\u00fczzam tedavisinde de kullan\u0131labilir.<\/span><\/p>\n

A.\u00a0<\/span>T\u00fcberk\u00fcloz Tedavisi<\/span><\/b><\/b><\/p>\n

Protionamide'in birincil ve en yerle\u015fik kullan\u0131m\u0131, \u00f6zellikle hastan\u0131n di\u011fer birinci basamak anti-t\u00fcberk\u00fcloz ila\u00e7lara diren\u00e7 geli\u015ftirdi\u011fi durumlarda t\u00fcberk\u00fcloz (TB) tedavisidir.<\/span><\/p>\n

Protionamid, \u00e7ok ilaca diren\u00e7li t\u00fcberk\u00fcloz (MDR-TB) ve yayg\u0131n ilaca diren\u00e7li t\u00fcberk\u00fcloz (XDR-TB) i\u00e7in ikinci basamak veya alternatif tedavi se\u00e7ene\u011fi olarak yayg\u0131n \u015fekilde kullan\u0131lmaktad\u0131r.<\/span><\/p>\n

Bu durumlarda Protionamide, daha etkili ve kapsaml\u0131 bir tedavi rejimi olu\u015fturmak i\u00e7in tipik olarak pirazinamid, etambutol ve florokinolonlar gibi di\u011fer anti-t\u00fcberk\u00fcloz ajanlarla birlikte kullan\u0131l\u0131r.<\/span><\/p>\n

B.\u00a0<\/span>\u00c7ok \u0130laca Diren\u00e7li T\u00fcberk\u00fclozda (\u00c7\u0130D-TB) Kullan\u0131m:<\/span><\/b><\/b><\/p>\n

\u00c7\u0130D-TB, en g\u00fc\u00e7l\u00fc ilk basamak anti-t\u00fcberk\u00fcloz ila\u00e7lar\u0131ndan en az ikisine, izoniazid ve rifampisine diren\u00e7li bir t\u00fcberk\u00fcloz t\u00fcr\u00fcd\u00fcr.<\/span><\/p>\n

Protionamid, \u00f6zellikle hastan\u0131n di\u011fer ikinci basamak anti-t\u00fcberk\u00fcloz ila\u00e7lara yan\u0131t vermedi\u011fi veya bunlar\u0131 tolere edemedi\u011fi durumlarda, \u00c7\u0130D-TB tedavisinde etkili bulunmu\u015ftur.<\/span><\/p>\n

Protionamide'in MDR-TB i\u00e7in tedavi rejimine dahil edilmesi, tedavi sonu\u00e7lar\u0131n\u0131n iyile\u015ftirilmesine yard\u0131mc\u0131 olabilir ve ba\u015far\u0131l\u0131 hastal\u0131k y\u00f6netimi \u015fans\u0131n\u0131 art\u0131rabilir.<\/span><\/p>\n

C.\u00a0<\/span>Yayg\u0131n \u0130laca Diren\u00e7li T\u00fcberk\u00fcloz (XDR-TB) Tedavisi:<\/span><\/b><\/b><\/p>\n

XDR-TB, izoniazid ve rifampisinin yan\u0131 s\u0131ra herhangi bir florokinolona ve enjekte edilebilir \u00fc\u00e7 ikinci basamak ila\u00e7tan (amikasin, kanamisin veya kapreomisin) en az birine kar\u015f\u0131 diren\u00e7li olan, ilaca diren\u00e7li t\u00fcberk\u00fclozun daha da \u015fiddetli bir \u015feklidir.<\/span><\/p>\n

Protionamid, XDR-TB tedavisinde kritik bir bile\u015fen olarak kabul edilmi\u015ftir, \u00e7\u00fcnk\u00fc tedavisi zor olan bu vakalar i\u00e7in daha etkili ve \u00f6zel tedavi rejimleri olu\u015fturmak i\u00e7in kullan\u0131labilir.<\/span><\/p>\n

D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (WHO), Protionamide'i XDR-TB'nin y\u00f6netimine y\u00f6nelik tavsiyelerine dahil ederek bu k\u00fcresel halk sa\u011fl\u0131\u011f\u0131 sorununun ele al\u0131nmas\u0131ndaki \u00f6nemini vurgulam\u0131\u015ft\u0131r.<\/span><\/p>\n

D.\u00a0<\/span>Lepra Tedavisi:<\/span><\/b><\/b><\/p>\n

Daha az yayg\u0131n olmakla birlikte Protionamide, Mycobacterium leprae'nin neden oldu\u011fu bir ba\u015fka mikobakteriyel enfeksiyon olan c\u00fczzam tedavisinde de kullan\u0131lm\u0131\u015ft\u0131r.<\/span><\/p>\n

Baz\u0131 durumlarda, \u00f6zellikle hastan\u0131n standart lepra tedavilerine diren\u00e7 geli\u015ftirdi\u011fi durumlarda, Protionamide alternatif veya tamamlay\u0131c\u0131 bir tedavi se\u00e7ene\u011fi olarak kullan\u0131labilir.<\/span><\/p>\n

Protionamid'in leprada kullan\u0131m\u0131 genellikle s\u0131n\u0131rl\u0131d\u0131r ve hastan\u0131n klinik ge\u00e7mi\u015finin ve enfekte eden su\u015fun spesifik diren\u00e7 paternlerinin dikkatle de\u011ferlendirilmesini gerektirir.<\/span><\/p>\n

E.\u00a0<\/span>Dozaj ve Uygulama \u015eekli:<\/span><\/b><\/b><\/p>\n

Protionamid tipik olarak a\u011f\u0131zdan uygulan\u0131r ve dozaj hastan\u0131n kilosuna, ya\u015f\u0131na ve spesifik tedavi rejimine g\u00f6re belirlenir.<\/span><\/p>\n

Protionamide'in \u00f6nerilen dozu de\u011fi\u015febilir, ancak genellikle di\u011fer anti-t\u00fcberk\u00fcloz veya anti-lepra ila\u00e7lar\u0131 ile birlikte re\u00e7ete edilir.<\/span><\/p>\n

Protionamid tedavisi s\u0131ras\u0131nda hastan\u0131n tedaviye verdi\u011fi yan\u0131t\u0131n ve herhangi bir yan etkinin uygun \u015fekilde izlenmesi \u00e7ok \u00f6nemlidir.<\/span><\/p>\n

F.\u00a0<\/span>D\u00fczenleyici Onaylar ve Y\u00f6nergeler:<\/span><\/b><\/b><\/p>\n

Protionamide Hindistan, Rusya ve baz\u0131 Avrupa \u00fclkeleri de dahil olmak \u00fczere bir\u00e7ok \u00fclkede t\u00fcberk\u00fcloz tedavisi i\u00e7in onaylanm\u0131\u015ft\u0131r.<\/span><\/p>\n

D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (WHO), Protionamide'i \u00c7\u0130D-TB ve XDR-TB tedavisi i\u00e7in Temel \u0130la\u00e7lar Listesi'ne dahil ederek ilaca diren\u00e7li t\u00fcberk\u00fcloz y\u00f6netimindeki \u00f6nemini kabul etmi\u015ftir.<\/span><\/p>\n

DS\u00d6 ve ulusal TB kontrol programlar\u0131 gibi ulusal ve uluslararas\u0131 k\u0131lavuzlar, \u00e7e\u015fitli t\u00fcberk\u00fcloz tedavi rejimlerinde Protionamide kullan\u0131m\u0131na ili\u015fkin tavsiyeler sunmaktad\u0131r.<\/span><\/p>\n

6.\u00a0<\/span>Farmakokinetik ve Dozaj:<\/span><\/b><\/b><\/p>\n

Protionamid tipik olarak a\u011f\u0131zdan uygulan\u0131r ve \u00f6nerilen dozaj spesifik tedavi rejimine ve hastan\u0131n kilosuna ve ya\u015f\u0131na ba\u011fl\u0131d\u0131r.<\/span><\/p>\n

\u0130la\u00e7 gastrointestinal sistemden iyi emilir ve oral uygulamadan sonra 1-2 saat i\u00e7inde pik plazma konsantrasyonlar\u0131na ula\u015f\u0131l\u0131r.<\/span><\/p>\n

Protionamid \u00f6ncelikle karaci\u011fer taraf\u0131ndan metabolize edilir ve yakla\u015f\u0131k 2-3 saatlik bir yar\u0131lanma \u00f6mr\u00fc ile b\u00f6brekler yoluyla at\u0131l\u0131r.<\/span><\/p>\n

A.\u00a0<\/span>Farmakokinetik<\/span><\/b><\/b><\/p>\n

a.\u00a0<\/span>Absorpsiyon<\/span><\/b><\/b><\/p>\n

Protionamid tipik olarak a\u011f\u0131zdan uygulan\u0131r ve gastrointestinal sistemden iyi emilir.<\/span><\/p>\n

Oral uygulamadan sonra, pik plazma konsantrasyonlar\u0131na tipik olarak 1-2 saat i\u00e7inde ula\u015f\u0131l\u0131r, bu da nispeten h\u0131zl\u0131 bir emilim oldu\u011funu g\u00f6sterir.<\/span><\/p>\n

Protionamid'in oral biyoyararlan\u0131m\u0131n\u0131n 60-80% aral\u0131\u011f\u0131nda oldu\u011fu bildirilmi\u015ftir, bu da ba\u011f\u0131rsaktan iyi emilim oldu\u011funu g\u00f6stermektedir.<\/span><\/p>\n

b.\u00a0<\/span>Da\u011f\u0131t\u0131m<\/span><\/b><\/b><\/p>\n

Protionamide emildikten sonra v\u00fccutta geni\u015f \u00e7apta da\u011f\u0131l\u0131r.<\/span><\/p>\n

Y\u00fcksek konsantrasyonlara ula\u015fabildi\u011fi akci\u011ferler de dahil olmak \u00fczere \u00e7e\u015fitli doku ve organlara n\u00fcfuz edebilir.<\/span><\/p>\n

Protionamidin kan-beyin bariyerini ge\u00e7erek merkezi sinir sistemine ula\u015ft\u0131\u011f\u0131 bilinmektedir.<\/span><\/p>\n

Protionamid'in da\u011f\u0131l\u0131m hacminin 1-2 L\/kg civar\u0131nda oldu\u011fu tahmin edilmektedir, bu da nispeten geni\u015f bir da\u011f\u0131l\u0131ma i\u015faret etmektedir.<\/span><\/p>\n

c.\u00a0<\/span>Metabolizma ve Eliminasyon<\/span><\/b><\/b><\/p>\n

Protionamid \u00f6ncelikle karaci\u011fer taraf\u0131ndan metabolize edilir ve burada \u00e7e\u015fitli biyotransformasyon reaksiyonlar\u0131na u\u011frar.<\/span><\/p>\n

Ana metabolik yol, \u00f6n ilac\u0131n aktivasyonundan sorumlu ayn\u0131 enzim olan EthA enzimi taraf\u0131ndan Protionamid'in oksidatif deaminasyonunu i\u00e7erir.<\/span><\/p>\n

Konjugasyon reaksiyonlar\u0131 ve daha ileri oksidasyon ad\u0131mlar\u0131 dahil olmak \u00fczere di\u011fer metabolik yollar da dahil olabilir.<\/span><\/p>\n

Protionamid metabolitleri a\u011f\u0131rl\u0131kl\u0131 olarak b\u00f6brekler yoluyla elimine edilir ve bildirilen yar\u0131lanma \u00f6mr\u00fc yakla\u015f\u0131k 2-3 saattir.<\/span><\/p>\n

B.\u00a0<\/span>Dozaj ve Uygulama<\/span><\/b><\/b><\/p>\n

a.\u00a0<\/span>\u00d6nerilen Dozaj<\/span><\/b><\/b><\/p>\n

T\u00fcberk\u00fcloz tedavisi i\u00e7in \u00f6nerilen Protionamide dozu, spesifik tedavi rejimine ve hastan\u0131n \u00f6zelliklerine ba\u011fl\u0131 olarak de\u011fi\u015fir.<\/span><\/p>\n

Tipik yeti\u015fkin dozlar\u0131, genellikle iki veya \u00fc\u00e7 uygulamaya b\u00f6l\u00fcnerek g\u00fcnde 0,5 ila 1 gram aras\u0131nda de\u011fi\u015fir.<\/span><\/p>\n

Dozaj hastan\u0131n kilosuna, ya\u015f\u0131na ve tedaviye verdi\u011fi klinik yan\u0131ta g\u00f6re ayarlanabilir.<\/span><\/p>\n

b.\u00a0<\/span>Dozaj Ayarlamalar\u0131<\/span><\/b><\/b><\/p>\n

Karaci\u011fer veya b\u00f6brek fonksiyon bozuklu\u011fu olan hastalarda, artan advers etki riskini \u00f6nlemek i\u00e7in Protionamid dozunun azalt\u0131lmas\u0131 gerekebilir.<\/span><\/p>\n

Protionamid tedavisi s\u0131ras\u0131nda karaci\u011fer ve b\u00f6brek fonksiyonlar\u0131n\u0131n dikkatle izlenmesi gereklidir ve doz buna g\u00f6re ayarlanabilir.<\/span><\/p>\n

Ciddi advers etkiler veya intolerans durumunda, Protionamid dozunun ge\u00e7ici olarak azalt\u0131lmas\u0131 veya tedavinin ge\u00e7ici olarak kesilmesi gerekebilir.<\/span><\/p>\n

c.\u00a0<\/span>Y\u00f6netim<\/span><\/b><\/b><\/p>\n

Protionamid tipik olarak yiyecekle birlikte veya yiyeceksiz olarak a\u011f\u0131zdan uygulan\u0131r.<\/span><\/p>\n

Tedavinin genel etkinli\u011fini etkileyebilece\u011finden, re\u00e7ete edilen doz program\u0131na uymak ve dozlar\u0131 ka\u00e7\u0131rmamak veya atlamamak \u00f6nemlidir.<\/span><\/p>\n

Baz\u0131 durumlarda, Protionamide di\u011fer t\u00fcberk\u00fcloz veya c\u00fczzam kar\u015f\u0131t\u0131 ila\u00e7larla birlikte kullan\u0131labilir, \u00f6zel dozaj ve uygulama rejimi hastan\u0131n ihtiya\u00e7lar\u0131na g\u00f6re uyarlan\u0131r.<\/span><\/p>\n

d.\u00a0<\/span>Farmakokinetik Hususlar<\/span><\/b><\/b><\/p>\n

Protionamid'in nispeten k\u0131sa yar\u0131lanma \u00f6mr\u00fc (2-3 saat), terap\u00f6tik ila\u00e7 seviyelerini korumak i\u00e7in g\u00fcnde birden fazla uygulama gerektirebilir.<\/span><\/p>\n

G\u0131da al\u0131m\u0131, e\u015flik eden ila\u00e7lar ve bireysel hasta \u00f6zellikleri gibi fakt\u00f6rler Protionamid'in farmakokineti\u011fini etkileyebilir ve doz ayarlamalar\u0131 gerektirebilir.<\/span><\/p>\n

Terap\u00f6tik ila\u00e7 takibi baz\u0131 durumlarda hastan\u0131n Protionamide seviyelerinin istenen terap\u00f6tik aral\u0131kta olmas\u0131n\u0131 sa\u011flamak i\u00e7in faydal\u0131 olabilir.<\/span><\/p>\n

7.\u00a0<\/span>Yan Etkiler ve \u00d6nlemler<\/span><\/b><\/b><\/p>\n

Protionamide ile ili\u015fkili yayg\u0131n advers etkiler bulant\u0131, kusma, kar\u0131n a\u011fr\u0131s\u0131 ve hepatotoksisiteyi (karaci\u011fer toksisitesi) i\u00e7erir.<\/span><\/p>\n

Protionamid tedavisi s\u0131ras\u0131nda karaci\u011fer fonksiyonlar\u0131n\u0131n dikkatle izlenmesi gereklidir ve ciddi karaci\u011fer hasar\u0131 durumlar\u0131nda dozun ayarlanmas\u0131 veya tedavinin kesilmesi gerekebilir.<\/span><\/p>\n

\u00d6nceden karaci\u011fer veya b\u00f6brek rahats\u0131zl\u0131\u011f\u0131 olan hastalar daha y\u00fcksek yan etki riski alt\u0131nda olabilir ve daha yak\u0131ndan izlenmeleri gerekebilir.<\/span><\/p>\n

8.\u00a0<\/span>Ruhsatland\u0131rma Durumu ve Klinik \u00c7al\u0131\u015fmalar<\/span><\/b><\/b><\/p>\n

Protionamide Hindistan, Rusya ve baz\u0131 Avrupa \u00fclkeleri de dahil olmak \u00fczere bir\u00e7ok \u00fclkede t\u00fcberk\u00fcloz tedavisi i\u00e7in onaylanm\u0131\u015ft\u0131r.<\/span><\/p>\n

D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc'n\u00fcn \u00c7\u0130D-TB ve XDR-TB tedavisi i\u00e7in Temel \u0130la\u00e7lar Listesi'nde yer almaktad\u0131r.<\/span><\/p>\n

Devam eden klinik ara\u015ft\u0131rmalar, Protionamide'in \u00e7e\u015fitli tedavi rejimlerinde kullan\u0131m\u0131n\u0131 ve tolere edilebilirli\u011fi ve etkinli\u011fi iyile\u015ftirmek i\u00e7in yeni form\u00fclasyonlar\u0131n geli\u015ftirilmesini ara\u015ft\u0131rmaktad\u0131r.<\/span><\/p>\n

9.\u00a0<\/span>\u00dcretim ve Tedarik<\/span><\/b><\/b><\/p>\n

Protionamid tipik olarak 2-aminotiyazol\u00fcn \u00e7e\u015fitli reaktiflerle reaksiyonunu i\u00e7eren kimyasal sentez s\u00fcre\u00e7leri yoluyla \u00fcretilir.<\/span><\/p>\n

Protionamide'in \u00fcretimi ve tedariki, gerekli \u00fcretim kabiliyetlerine ve d\u00fczenleyici onaylara sahip belirli ila\u00e7 \u015firketleri veya ara\u015ft\u0131rma kurulu\u015flar\u0131 ile s\u0131n\u0131rl\u0131 olabilir.<\/span><\/p>\n

Protionamide'e eri\u015fim, farkl\u0131 pazarlardaki bulunabilirlik ve da\u011f\u0131t\u0131m kanallar\u0131na tabi oldu\u011fundan, belirli \u00fclke veya b\u00f6lgeye ba\u011fl\u0131 olarak de\u011fi\u015febilir.<\/span><\/p>","protected":false},"excerpt":{"rendered":"

1. Genel Bak\u0131\u015f Prothionamide olarak da bilinen Protionamide, tiyoamid bile\u015fik s\u0131n\u0131f\u0131na ait sentetik bir antibakteriyel ajand\u0131r. \u00d6ncelikle t\u00fcberk\u00fcloz tedavisinde, \u00f6zellikle hastan\u0131n di\u011fer birinci basamak anti-t\u00fcberk\u00fcloz ila\u00e7lara diren\u00e7 geli\u015ftirdi\u011fi durumlarda kullan\u0131l\u0131r. Protionamid, \u00e7oklu ilaca diren\u00e7li [...] i\u00e7in ikinci basamak veya alternatif bir tedavi se\u00e7ene\u011fi olarak kullan\u0131lm\u0131\u015ft\u0131r.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"yoast_head":"\nHow Protionamide's Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment! - China Chemical Manufacturer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/longchangextracts.com\/tr\/protionamidlerin-cigir-acan-mekanizmasi-tuberkuloz-tedavisinde-nasil-devrim-yaratiyor\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How Protionamide's Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment! - China Chemical Manufacturer\" \/>\n<meta property=\"og:description\" content=\"1.\u00a0Overview Protionamide, also known as Prothionamide, is a synthetic antibacterial agent that belongs to the thioamide class of compounds. It is primarily used in the treatment of tuberculosis, particularly in cases where the patient has developed resistance to other first-line anti-tuberculosis drugs. Protionamide has been used as a second-line or alternative treatment option for multidrug-resistant […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/longchangextracts.com\/tr\/protionamidlerin-cigir-acan-mekanizmasi-tuberkuloz-tedavisinde-nasil-devrim-yaratiyor\/\" \/>\n<meta property=\"og:site_name\" content=\"China Chemical Manufacturer\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-16T08:28:19+00:00\" \/>\n<meta name=\"author\" content=\"longcha9\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"longcha9\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/\",\"url\":\"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/\",\"name\":\"How Protionamide's Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment! - China Chemical Manufacturer\",\"isPartOf\":{\"@id\":\"https:\/\/longchangextracts.com\/#website\"},\"datePublished\":\"2024-04-16T08:28:19+00:00\",\"dateModified\":\"2024-04-16T08:28:19+00:00\",\"author\":{\"@id\":\"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869\"},\"breadcrumb\":{\"@id\":\"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/longchangextracts.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How Protionamide’s Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/longchangextracts.com\/#website\",\"url\":\"https:\/\/longchangextracts.com\/\",\"name\":\"China Chemical Manufacturer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/longchangextracts.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869\",\"name\":\"longcha9\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/longchangextracts.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g\",\"caption\":\"longcha9\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Protionamide'in \u00c7\u0131\u011f\u0131r A\u00e7an Mekanizmas\u0131 T\u00fcberk\u00fcloz Tedavisinde Nas\u0131l Devrim Yarat\u0131yor! - \u00c7in Kimyasal \u00dcreticisi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/longchangextracts.com\/tr\/protionamidlerin-cigir-acan-mekanizmasi-tuberkuloz-tedavisinde-nasil-devrim-yaratiyor\/","og_locale":"tr_TR","og_type":"article","og_title":"How Protionamide's Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment! - China Chemical Manufacturer","og_description":"1.\u00a0Overview Protionamide, also known as Prothionamide, is a synthetic antibacterial agent that belongs to the thioamide class of compounds. It is primarily used in the treatment of tuberculosis, particularly in cases where the patient has developed resistance to other first-line anti-tuberculosis drugs. Protionamide has been used as a second-line or alternative treatment option for multidrug-resistant […]","og_url":"https:\/\/longchangextracts.com\/tr\/protionamidlerin-cigir-acan-mekanizmasi-tuberkuloz-tedavisinde-nasil-devrim-yaratiyor\/","og_site_name":"China Chemical Manufacturer","article_published_time":"2024-04-16T08:28:19+00:00","author":"longcha9","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"longcha9","Tahmini okuma s\u00fcresi":"9 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/","url":"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/","name":"Protionamide'in \u00c7\u0131\u011f\u0131r A\u00e7an Mekanizmas\u0131 T\u00fcberk\u00fcloz Tedavisinde Nas\u0131l Devrim Yarat\u0131yor! - \u00c7in Kimyasal \u00dcreticisi","isPartOf":{"@id":"https:\/\/longchangextracts.com\/#website"},"datePublished":"2024-04-16T08:28:19+00:00","dateModified":"2024-04-16T08:28:19+00:00","author":{"@id":"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869"},"breadcrumb":{"@id":"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/longchangextracts.com\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/longchangextracts.com\/"},{"@type":"ListItem","position":2,"name":"How Protionamide’s Breakthrough Mechanism is Revolutionizing Tuberculosis Treatment!"}]},{"@type":"WebSite","@id":"https:\/\/longchangextracts.com\/#website","url":"https:\/\/longchangextracts.com\/","name":"\u00c7in Kimyasal \u00dcreticisi","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/longchangextracts.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869","name":"longcha9","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/longchangextracts.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g","caption":"longcha9"}}]}},"_links":{"self":[{"href":"https:\/\/longchangextracts.com\/tr\/wp-json\/wp\/v2\/posts\/3390"}],"collection":[{"href":"https:\/\/longchangextracts.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/longchangextracts.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/longchangextracts.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/longchangextracts.com\/tr\/wp-json\/wp\/v2\/comments?post=3390"}],"version-history":[{"count":0,"href":"https:\/\/longchangextracts.com\/tr\/wp-json\/wp\/v2\/posts\/3390\/revisions"}],"wp:attachment":[{"href":"https:\/\/longchangextracts.com\/tr\/wp-json\/wp\/v2\/media?parent=3390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/longchangextracts.com\/tr\/wp-json\/wp\/v2\/categories?post=3390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/longchangextracts.com\/tr\/wp-json\/wp\/v2\/tags?post=3390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}